N
ELOX

Nuveen’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Nuveen’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,837
Closed -$377K – 3602
2021
Q1 		$377K Buy
2,837
+105
+4% +$16K ﹤0.01% 3138
2020
Q4 		$435K Buy
2,732
+37
+1% +$4.52K ﹤0.01% 3071
2020
Q3 		$283K Sell
2,695
-235
-8% -$28.2K ﹤0.01% 3102
2020
Q2 		$355K Buy
2,930
+3
+0.1% +$340 ﹤0.01% 3008
2020
Q1 		$230K Buy
2,927
+526
+22% +$85.6K ﹤0.01% 2972
2019
Q4 		$707K Sell
2,401
-560
-19% -$113K ﹤0.01% 2811
2019
Q3 		$535K Buy
2,961
+666
+29% +$189K ﹤0.01% 2927
2019
Q2 		$916K Buy
+2,295
New +$966K ﹤0.01% 2779

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen's ELOX Position: Q2 2021 in Review

Nuveen sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2021, closing a stake of 2,837 shares — an estimated $377K sold.

Nuveen first reported a position in ELOX in Q2 2019 and held it in 8 quarters. The position peaked at $916K in Q2 2019. 46 funds tracked by Wall St. Rank hold ELOX as of Q2 2021.

  • Nuveen reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 2,837 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $377K.
  • Nuveen first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Nuveen's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $916K in Q2 2019.
  • 46 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.